Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novartis AG Common Stock (NY:NVS)

136.32 +1.05 (+0.78%)
Streaming Delayed Price Updated: 11:12 AM EST, Dec 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Novartis AG Common Stock

< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
52 53 Next >
News headline image
2 Best Biotech Stocks to Buy for the Long Haul ↗
These two are among the largest pharma companies in the world. 
Via The Motley Fool
News headline image
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late ↗
You have to be patient when investing in pharma stocks. But sometimes the risk and the wait aren't worth the rewards. 
Via InvestorPlace
News headline image
Relay Therapeutics' Stock Price Premium Vs Peers Is Justified By Its Platform Technology, Analyst Says ↗
 
Via Benzinga
News headline image
Novartis Earnings Conference Call Is Coming Up, Here's What You Need To Know ↗
 
Via Benzinga
News headline image
Alzheimer's Disease Largely Remains A Mystery, With A Lack Of Highly Effective Treatments — Could Regulatory T-Cells (Tregs) Be The Answer? ↗
In many ways, Alzheimer's disease (AD) remains a mystery. Most common in those over 65, AD is the most common form of dementia, but its exact causes remain unclear, and treatments are unable to halt or... 
Via Benzinga
Novartis AG (NYSE: NVS) Records 52-Week High Thursday Morning
Via Investor Brand Network
News headline image
FDA Approves Pharming's Immune Disorder Drug, As First APDS Therapy ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Novartis? ↗
 
Via Benzinga
News headline image
Trillions In Biotech Stock Gains Trace Back To This Financier ↗
Frank did not grow up as son of a Wall Street banker. He began as the consummate outsider. 
Via Investor's Business Daily
News headline image
Epic Growth Story Predicted for Pharmaceutical Drug Delivery Market's Future: Johnson & Johnson, Novartis International, Merck
Stay up-to-date with Pharmaceutical Drug Delivery Market research offered by AMA Research. Check how key trends and emerging drivers are shaping this industry growth. 
Via SBWire
News headline image
Tilray Brands Consolidates Hold: Profits Will Drive Shares Higher
Tilray Brands moves lower on mixed results, but the bottom may be in, with positive FCF expected this quarter. The long-term catalyst is US legalization. 
Via MarketBeat
Topics Cannabis
News headline image
Emergent BioSolutions Soars: Analyst Upgrades Stock With Near 100% Upside After FDA's Positive Move ↗
 
Via Benzinga
News headline image
Top-Notch Biotech TG Therapeutics Logs 'Solid Jump' In Sales; Shares Rocket ↗
Shares are closing in on a buy point out of a consolidation. 
Via Investor's Business Daily
Pediatric Drugs Market Giants Spending Is Going to Boom : Pfizer, Bayer, Abbott Laboratories, Merck
NJ New Jersey, USA -- (SBWIRE) -- 04/10/2023 -- Latest Study on Industrial Growth of Pediatric Drugs Market 2022-2027. A detailed study accumulated to offer Latest insights about acute features of the... 
Via SBWire
News headline image
Cryoport Supports Clinical Trials And Commercial Therapies Across The High-Growth BioTech Industry: Is Its Current Stock Price An Opportunity? ↗
The global biotechnology industry was worth $859 billion in 2022, and it is predicted to reach $1.6 trillion by 2030, growing at a compound annual growth rate (CAGR) of 8.7% over the forecast period.  
Via Benzinga
News headline image
Novartis Shares Leap On Positive Clinical Trial Data
Swiss pharmaceutical giant Novartis leaped 5.11% in the past week following news that its Kisqali breast-cancer treatment cut the probability of relapse. 
Via MarketBeat
News headline image
6 Questions With Rocket Pharma's CEO On World Health Day: How The Biotech Is 'Changing The Narrative' ↗
Rocket Pharma (NASDAQ: RCKT) CEO Gaurav Shah is on a mission to "change the narrative" when it comes to rare diseases. 
Via Benzinga
News headline image
7 Very Undervalued Penny Stocks to Buy in April 2023 ↗
Undervalued penny stocks present investors who are very bullish on the near-term future with a high-risk, high-reward option. 
Via InvestorPlace
News headline image
The Byzantine Adderall Shortage Puts Teva And Others In The Hot Seat ↗
Millions of people are scrambling to get their ADHD medication. Here's why. 
Via Investor's Business Daily
News headline image
Stock Market Rallies On Micron, Alibaba, Lululemon, Ebbing Bank Fears: Weekly Review ↗
The stock market rallied on ebbing bank fears and positive news from Micron, Alibaba and Lululemon Athletica. 
Via Investor's Business Daily
News headline image
What Bear Market? These 2 Winning Stocks Are Still Worth Buying. ↗
These two pharma stocks are rock-solid picks in any kind of market. 
Via The Motley Fool
News headline image
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider. 
Via Benzinga
News headline image
Elon Musk-Led Neuralink Seeks Human Trial Collaborators, Credit Suisse May Face Disciplinary Action, First Citizens Takeover Silicon Valley Bank: Today's Top Stories ↗
Benzinga 
Via Benzinga
News headline image
Novartis Surges As It Goes After Eli Lilly's Second Biggest Moneymaker ↗
The battle in early-stage breast cancer is heating up as Novartis enters the ring. 
Via Investor's Business Daily
News headline image
Why Novartis Shares Are Trading Higher Premarket Today ↗
Novartis AG (NYSE: NVS) shares are trading higher in the premarket session after its breast cancer drug showed clinical benefit in early-stage breast cancer. 
Via Benzinga
News headline image
First Republic Bank, KeyCorp And Other Big Stocks Moving Higher In Monday's Pre-Market Session ↗
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
News headline image
New research project aims to set standardized approach to lipoprotein(a) management
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
News headline image
2 Biotech Stocks That Could Make You Richer ↗
One is a well-established, large-cap drugmaker, while the other is still making a name for itself in the industry. 
Via The Motley Fool
News headline image
Two Big Pharma Companies Bow Out Of Neurology Drug Partnerships With Sangamo ↗
Two big-name partners have walked away from partnerships with Sangamo Therapeutics Inc (NASDAQ: SGMO) over a few days. 
Via Benzinga
News headline image
Novartis Reveals Long-Term Data Of Atrophy Gene Therapy Exhibiting Sustained Durability Of Up To 7.5 Years ↗
 
Via Benzinga
< Previous 1 2
...
25 26 27 28 29 30 31 32 33
...
52 53 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.